Heikamp et al. demonstrated that inhibiting the menin-MLL1 protein complex using VTP50469 could inhibit leukemogenesis in NUP98-rearranged leukemia models by disrupting interactions between NUP98 fusion proteins and chromatin. Here, NUP98 is linked to leukemia.